Table 2.

T stage, nodal status, and pathologic complete response in 85 triple-negative breast cancer patients and the subsets of patients with or without necrotic carcinomas

Characteristic	Study population (n = 85)	Necrotic carcinomas (n = 39)	Non-necrotic carcinomas (n = 46)	P-value
T stage				0.07
T1	14/85 (16)	3/39 (8)	11/46 (24)
T2	44/85 (52)	20/39 (51)	24/46 (52)
T3	27/85 (32)	16/39 (41)	11/46 (24)
Nodal status at staging				0.69
Positive	46/85 (54)	22/39 (56)	24/46 (52)
Negative	39/85 (46)	17/39 (44)	22/46 (48)
Nodal status at surgery				0.75
Positive	21/85 (25)	9/39 (23)	12/46 (26)
Negative	64/85 (75)	30/39 (77)	34/46 (74)
pCR status				0.99
pCR	37/85 (44)	17/39 (44)	20/46 (43)
Non-pCR	48/85 (56)	22/39 (56)	26/46 (57)

Data are number of patients (percent) with the exception of the P-value column. P-values comparing characteristic distributions between necrotic and non-necrotic patients used Chi-square test

pCR pathological complete response